Sunshine Biopharma Inc.: 10-Q filed 2020-08-19

Name: Sunshine Biopharma Inc.: 10-Q filed 2020-08-19
Creator: Sunshine Biopharma Inc.

What Sunshine Biopharma Inc. reported in its quarterly report filed 2020-08-19 (fiscal Q2 2020): 37 published measures, 106 facts as tagged in accession 0001654954-20-009340.

This filing

Form: 10-Q (quarterly report)
Filed: 2020-08-19
Fiscal period: fiscal Q2 2020
Accession: 0001654954-20-009340 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Sunshine Biopharma Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2020-06-30	138,517	USD
At 2019-12-31	98,142	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2020-06-30	749,430	USD
At 2019-12-31	833,527	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit
At 2020-06-30	-610,913	USD
At 2020-03-31	-816,302	USD
At 2019-12-31	-735,385	USD
At 2019-06-30	-816,302	USD
At 2019-03-31	-211,772	USD
At 2018-12-31	-55,753	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit	Days
At 2020-06-30	85,593	USD
At 2019-12-31	40,501	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2020-04-01 to 2020-06-30	-638,313	USD	91
2020-01-01 to 2020-06-30	-732,572	USD	182
2019-04-01 to 2019-06-30	-710,890	USD	91
2019-01-01 to 2019-06-30	-913,432	USD	181

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2020-01-01 to 2020-06-30	-113,050	USD	182
2019-01-01 to 2019-06-30	-281,423	USD	181

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Value	Unit	Days
2020-04-01 to 2020-06-30	15,145	USD	91
2020-01-01 to 2020-06-30	26,247	USD	182
2019-04-01 to 2019-06-30	3,033	USD	91
2019-01-01 to 2019-06-30	3,239	USD	181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2020-01-01 to 2020-06-30	159,007	USD	182
2019-01-01 to 2019-06-30	219,428	USD	181

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2020-01-01 to 2020-06-30	0	USD	182
2019-01-01 to 2019-06-30	-12,976	USD	181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2020-06-30	-18,167,208	USD
At 2019-12-31	-17,434,636	USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

Period	Value	Unit	Days
2020-04-01 to 2020-06-30	109,110,342	shares	91
2020-01-01 to 2020-06-30	78,975,458	shares	182
2019-04-01 to 2019-06-30	4,973,649	shares	91
2019-01-01 to 2019-06-30	4,641,040	shares	181

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

Period	Value	Unit	Days
2020-04-01 to 2020-06-30	-0.01	USD/shares	91
2020-01-01 to 2020-06-30	-0.01	USD/shares	182
2019-04-01 to 2019-06-30	-0.14	USD/shares	91
2019-01-01 to 2019-06-30	-0.2	USD/shares	181

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2020-06-30	26,352	USD
At 2019-12-31	32,456	USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2020-04-01 to 2020-06-30	-128,569	USD	91
2020-01-01 to 2020-06-30	-166,268	USD	182
2019-04-01 to 2019-06-30	-66,197	USD	91
2019-01-01 to 2019-06-30	-188,406	USD	181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2020-06-30	112,165	USD
At 2019-12-31	65,686	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2020-04-01 to 2020-06-30	20,363	USD	91
2020-01-01 to 2020-06-30	36,719	USD	182
2019-04-01 to 2019-06-30	18,342	USD	91
2019-01-01 to 2019-06-30	64,639	USD	181

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2020-06-30	686,196	USD
At 2019-12-31	833,527	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2020-06-30	89,883	USD
At 2019-12-31	96,882	USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

Period	Value	Unit	Days
At 2020-06-30	0	USD
At 2019-12-31	0	USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

Period	Value	Unit	Days
At 2020-06-30	0	USD
At 2019-12-31	430	USD

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

Period	Value	Unit	Days
At 2020-06-30	16,576	USD
At 2019-12-31	15,910	USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

Period	Value	Unit	Days
2020-04-01 to 2020-06-30	9,984	USD	91
2020-01-01 to 2020-06-30	17,203	USD	182
2019-04-01 to 2019-06-30	1,573	USD	91
2019-01-01 to 2019-06-30	1,667	USD	181

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

Period	Value	Unit	Days
2020-04-01 to 2020-06-30	5,161	USD	91
2020-01-01 to 2020-06-30	9,044	USD	182
2019-04-01 to 2019-06-30	1,460	USD	91
2019-01-01 to 2019-06-30	1,572	USD	181

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Unit	Days
2020-04-01 to 2020-06-30	USD	91
2020-01-01 to 2020-06-30	USD	182
2019-04-01 to 2019-06-30	USD	91
2019-01-01 to 2019-06-30	USD	181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2020-06-30	191,710,596	shares
At 2019-12-31	35,319,990	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2020-06-30	17,267,946	USD
At 2019-12-31	16,616,426	USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

Period	Value	Unit	Days
At 2020-06-30	-3,360	USD
At 2019-12-31	-2,495	USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

Period	Value	Unit	Days
At 2020-06-30	43,723	USD
At 2019-12-31	37,109	USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

Period	Value	Unit	Days
2020-04-01 to 2020-06-30	-637,837	USD	91
2020-01-01 to 2020-06-30	-733,437	USD	182
2019-04-01 to 2019-06-30	-708,391	USD	91
2019-01-01 to 2019-06-30	-911,718	USD	181

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

Period	Value	Unit	Days
2020-04-01 to 2020-06-30	-637,837	USD	91
2020-01-01 to 2020-06-30	-733,437	USD	182
2019-04-01 to 2019-06-30	-708,391	USD	91
2019-01-01 to 2019-06-30	-911,718	USD	181

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2020-04-01 to 2020-06-30	138,553	USD	91
2020-01-01 to 2020-06-30	183,471	USD	182
2019-04-01 to 2019-06-30	67,770	USD	91
2019-01-01 to 2019-06-30	190,073	USD	181

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

Period	Value	Unit	Days
2020-04-01 to 2020-06-30	3,491	USD	91
2020-01-01 to 2020-06-30	7,002	USD	182
2019-04-01 to 2019-06-30	3,415	USD	91
2019-01-01 to 2019-06-30	6,829	USD	181

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2020-04-01 to 2020-06-30	-509,744	USD	91
2020-01-01 to 2020-06-30	-566,304	USD	182
2019-04-01 to 2019-06-30	-64,568	USD	91
2019-01-01 to 2019-06-30	-142,789	USD	181

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

Period	Value	Unit	Days
2020-01-01 to 2020-06-30	0	USD	182
2019-01-01 to 2019-06-30	11,034	USD	181

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

Period	Value	Unit	Days
2020-01-01 to 2020-06-30	0	USD	182
2019-01-01 to 2019-06-30	0	USD	181

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2020-01-01 to 2020-06-30	-430	USD	182
2019-01-01 to 2019-06-30	1,023	USD	181

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

Period	Value	Unit	Days
2020-01-01 to 2020-06-30	666	USD	182
2019-01-01 to 2019-06-30	18,193	USD	181

Inspect the source

Entity: Sunshine Biopharma Inc. / CIK 0001402328
Captured: 2026-09-20T08:00:47.083Z
SEC response SHA-256: 089eb69bd01c2bc993f5073ccdb651eba31ddb7f7ea640d657095dcd4ddd9932

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001402328.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))